Literature DB >> 16638929

Simultaneous bone marrow and intestine transplantation promotes marrow-derived hematopoietic stem cell engraftment and chimerism.

Atsunori Nakao1, Hideyoshi Toyokawa, Kei Kimizuka, Michael A Nalesnik, Isao Nozaki, Robert J Bailey, Anthony J Demetris, Thomas E Starzl, Noriko Murase.   

Abstract

Organ allografts have been shown to provide a syngeneic microenvironment for organ-based donor hematopoietic stem cells to maintain long-lasting chimerism after transplantation. We hypothesized that organ allografts would also support engraftment and hematopoiesis of adjunctively infused donor marrow stem cells, syngeneic to organ grafts, in nonmyeloablated recipients. In BN-to-LEW and GFP-to-ACI rat combinations, donor bone marrow (BM) infusion together with small intestine transplantation (SITx) under short-course tacrolimus immunosuppression resulted in persistent macrochimerism (more than 5%) for 150 days. In contrast, after BM infusion or SITx alone, chimerism was temporary and disappeared by day 100. Y-chromosome polymerase chain reaction (PCR) in sex-mismatched male BM plus female intestine or female BM plus male intestine transplantation into female recipients suggested that persistent macrochimerism was derived from infused BM. BM infusion together with lymphoid-depleted intestine grafts also supported macrochimerism development; however, third-party intestine grafts did not. After GFP-positive BM plus wild-type (WT) SITx into ACI, large numbers of GFP-positive leukocytes were found in WT intestine grafts. Isolated cells from WT intestine grafts developed GFP-positive CFU-Cs and propagated multilineage GFP-positive leukocytes when adoptively transferred into lethally irradiated WT recipients. These findings suggest that intestine allograft supports simultaneously infused donor (syngeneic to organ grafts) marrow stem cell engraftment, differentiation, and persistence of chimerism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16638929      PMCID: PMC1895884          DOI: 10.1182/blood-2006-02-004341

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

1.  Transplantation of the bone marrow microenvironment leads to hematopoietic chimerism without cytoreductive conditioning.

Authors:  A W Bingaman; S Y Waitze; D Z Alexander; H R Cho; A Lin; C Tucker-Burden; S R Cowan; T C Pearson; C P Larsen
Journal:  Transplantation       Date:  2000-06-27       Impact factor: 4.939

2.  Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation.

Authors:  Atsushi Asakura; Michael A Rudnicki
Journal:  Exp Hematol       Date:  2002-11       Impact factor: 3.084

3.  Actively acquired tolerance of foreign cells.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Nature       Date:  1953-10-03       Impact factor: 49.962

4.  3D-confocal structural analysis of bone marrow-derived renal tubular cells during renal ischemia/reperfusion injury.

Authors:  Hideyoshi Toyokawa; Atsunori Nakao; Donna B Stolz; Anna J Romanosky; Michael A Nalesnik; Joao Seda Neto; Takashi Kaizu; Anthony J Demetris; Noriko Murase
Journal:  Lab Invest       Date:  2006-01       Impact factor: 5.662

5.  Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both.

Authors:  N Murase; Q Ye; M A Nalesnik; A J Demetris; K Abu-Elmagd; J Reyes; N Ichikawa; T Okuda; J J Fung; T E Starzl
Journal:  Transplantation       Date:  2000-12-15       Impact factor: 4.939

6.  Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment.

Authors:  T Wekerle; J Kurtz; H Ito; J V Ronquillo; V Dong; G Zhao; J Shaffer; M H Sayegh; M Sykes
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

7.  Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.

Authors:  R Storb; C Yu; J L Wagner; H J Deeg; R A Nash; H P Kiem; W Leisenring; H Shulman
Journal:  Blood       Date:  1997-04-15       Impact factor: 22.113

Review 8.  Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis.

Authors:  Magda Kucia; Ryan Reca; Katarzyna Miekus; Jens Wanzeck; Wojtek Wojakowski; Anna Janowska-Wieczorek; Janina Ratajczak; Mariusz Z Ratajczak
Journal:  Stem Cells       Date:  2005-05-11       Impact factor: 6.277

9.  Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo.

Authors:  C R Bjornson; R L Rietze; B A Reynolds; M C Magli; A L Vescovi
Journal:  Science       Date:  1999-01-22       Impact factor: 47.728

10.  Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance.

Authors:  T Wekerle; M H Sayegh; J Hill; Y Zhao; A Chandraker; K G Swenson; G Zhao; M Sykes
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

View more
  3 in total

1.  CTGF, intestinal stellate cells and carcinoid fibrogenesis.

Authors:  M Kidd; I M Modlin; M D Shapiro; R L Camp; S M Mane; W Usinger; J R Murren
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

2.  Characterization of transplanted green fluorescent protein+ bone marrow cells into adipose tissue.

Authors:  Koji Tomiyama; Noriko Murase; Donna Beer Stolz; Hideyoshi Toyokawa; Daniel R O'Donnell; Darren M Smith; Jason R Dudas; J Peter Rubin; Kacey G Marra
Journal:  Stem Cells       Date:  2007-11-01       Impact factor: 6.277

3.  Macrochimerism in Intestinal Transplantation: Association With Lower Rejection Rates and Multivisceral Transplants, Without GVHD.

Authors:  J Zuber; S Rosen; B Shonts; B Sprangers; T M Savage; S Richman; S Yang; S P Lau; S DeWolf; D Farber; G Vlad; E Zorn; W Wong; J Emond; B Levin; M Martinez; T Kato; M Sykes
Journal:  Am J Transplant       Date:  2015-05-18       Impact factor: 8.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.